C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN) are two diseases that have a ...

Company officials say they are focusing on "more disciplined managed products" as they prepare to exit PPOs in 2026 that currently cover 800,000 members, including 600,000 people enrolled in Medicare ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

The Joint Commission revamps pediatric care standards, prioritizing children's unique healthcare needs for safer, more effective hospital experiences.

An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Sarepta continues to work with regulators to complete the safety label update for Elevidys, and they are discussing an approach for risk mitigation for non-ambulatory patients.

In a press release in advance of an 8 a.m. earnings call, the company said that the second-quarter consolidated medical-care ratio of 89.4% increased 430 basis points year-over-year. The increase was ...

Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the ...

Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to ...

Health policy researcher Geoffrey Joyce argues that only delinking compensation from the list price of a drug will lower drug ...

An expert discusses how real-world evidence is driving gene therapy adoption in BCG-unresponsive disease primarily through ...